Incyte (INCY) Share-based Compensation (2010 - 2026)
Incyte posted quarterly Share-based Compensation of $64.1 million for Q1 2026, up 5.16% year-on-year from $61.0 million in Q1 2025, and up 3.17% on a QoQ basis from $62.2 million in Q4 2025.
Incyte (INCY) has 17 years of Share-based Compensation data on file, last reported at $64.1 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 5.16% year-over-year to $64.1 million; the trailing twelve-month figure through Mar 2026 stood at $252.5 million (down 5.53% YoY), and the FY2025 full-year result was $249.3 million, down 6.28% from the prior year.
- Share-based Compensation for Q1 2026 stood at $64.1 million, up from $62.2 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $77.9 million in Q3 2024 and bottomed at $43.8 million in Q1 2022.
- The 5-year median for Share-based Compensation is $59.8 million (2024), against an average of $57.9 million.
- The widest annual swing landed in 2024, when Share-based Compensation surged 62.34%; it then slipped 20.95% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $52.7 million in 2022, then gained by 13.88% to $60.0 million in 2023, then advanced by 19.55% to $71.7 million in 2024, then retreated by 13.33% to $62.2 million in 2025, then advanced by 3.17% to $64.1 million in 2026.
- The last three Share-based Compensation figures came in at $64.1 million (Q1 2026), $62.2 million (Q4 2025), and $61.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 64.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.13 Mn |
| Mar 31, 2026 | 64.13 Mn |
| Dec 31, 2025 | 62.16 Mn |
| Dec 31, 2025 | 62.16 Mn |
| Sep 30, 2025 | 61.60 Mn |
| Sep 30, 2025 | 61.60 Mn |
| Jun 30, 2025 | 64.61 Mn |
| Jun 30, 2025 | 64.61 Mn |
| Mar 31, 2025 | 60.98 Mn |
| Mar 31, 2025 | 60.98 Mn |
| Dec 31, 2024 | 71.72 Mn |
| Dec 31, 2024 | 71.72 Mn |
| Sep 30, 2024 | 77.92 Mn |
| Sep 30, 2024 | 77.92 Mn |
| Jun 30, 2024 | 56.64 Mn |
| Jun 30, 2024 | 56.64 Mn |
| Mar 31, 2024 | 59.78 Mn |
| Mar 31, 2024 | 59.78 Mn |
| Dec 31, 2023 | 59.99 Mn |
| Dec 31, 2023 | 59.99 Mn |
| Sep 30, 2023 | 48.00 Mn |
| Sep 30, 2023 | 48.00 Mn |
| Jun 30, 2023 | 54.52 Mn |
| Jun 30, 2023 | 54.52 Mn |
| Mar 31, 2023 | 53.38 Mn |
| Mar 31, 2023 | 53.38 Mn |
| Dec 31, 2022 | 52.68 Mn |
| Dec 31, 2022 | 52.68 Mn |
| Sep 30, 2022 | 45.40 Mn |
| Sep 30, 2022 | 45.40 Mn |
| Jun 30, 2022 | 46.50 Mn |
| Jun 30, 2022 | 46.50 Mn |
| Mar 31, 2022 | 43.84 Mn |
| Mar 31, 2022 | 43.84 Mn |
| Dec 31, 2021 | 48.22 Mn |
| Dec 31, 2021 | 48.22 Mn |
| Sep 30, 2021 | 42.70 Mn |
| Sep 30, 2021 | 42.70 Mn |
| Jun 30, 2021 | 44.80 Mn |
| Jun 30, 2021 | 44.80 Mn |
| Mar 31, 2021 | 47.36 Mn |
| Mar 31, 2021 | 47.36 Mn |
| Dec 31, 2020 | 45.26 Mn |
| Dec 31, 2020 | 45.26 Mn |
| Sep 30, 2020 | 43.80 Mn |
| Sep 30, 2020 | 43.80 Mn |
| Jun 30, 2020 | 46.30 Mn |
| Jun 30, 2020 | 46.30 Mn |
| Mar 31, 2020 | 42.51 Mn |
| Mar 31, 2020 | 42.51 Mn |
| Dec 31, 2019 | 42.02 Mn |
| Dec 31, 2019 | 42.02 Mn |
| Sep 30, 2019 | 43.40 Mn |
| Sep 30, 2019 | 43.40 Mn |
| Jun 30, 2019 | 40.60 Mn |
| Jun 30, 2019 | 40.60 Mn |
| Mar 31, 2019 | 40.60 Mn |
| Mar 31, 2019 | 40.60 Mn |
| Dec 31, 2018 | 37.40 Mn |
| Dec 31, 2018 | 37.40 Mn |
| Sep 30, 2018 | 38.00 Mn |
| Sep 30, 2018 | 38.00 Mn |
| Jun 30, 2018 | 36.60 Mn |
| Jun 30, 2018 | 36.60 Mn |
| Mar 31, 2018 | 36.22 Mn |
| Mar 31, 2018 | 36.22 Mn |
| Dec 31, 2017 | 33.76 Mn |
| Dec 31, 2017 | 33.76 Mn |
| Sep 30, 2017 | 34.90 Mn |
| Sep 30, 2017 | 34.90 Mn |
| Jun 30, 2017 | 33.80 Mn |
| Jun 30, 2017 | 33.80 Mn |
| Mar 31, 2017 | 30.60 Mn |
| Mar 31, 2017 | 30.60 Mn |
| Dec 31, 2016 | 27.60 Mn |
| Dec 31, 2016 | 27.60 Mn |
| Sep 30, 2016 | 26.50 Mn |
| Sep 30, 2016 | 26.50 Mn |
| Jun 30, 2016 | 21.30 Mn |
| Jun 30, 2016 | 21.30 Mn |
| Mar 31, 2016 | 20.80 Mn |
| Mar 31, 2016 | 20.80 Mn |
| Dec 31, 2015 | 17.10 Mn |
| Dec 31, 2015 | 17.10 Mn |
| Sep 30, 2015 | 17.60 Mn |
| Sep 30, 2015 | 17.60 Mn |
| Jun 30, 2015 | 17.60 Mn |
| Jun 30, 2015 | 17.60 Mn |
| Mar 31, 2015 | 17.56 Mn |
| Mar 31, 2015 | 17.56 Mn |
| Dec 31, 2014 | 15.90 Mn |
| Dec 31, 2014 | 15.90 Mn |
| Sep 30, 2014 | 15.50 Mn |
| Sep 30, 2014 | 15.50 Mn |
| Jun 30, 2014 | 15.50 Mn |
| Jun 30, 2014 | 15.50 Mn |
| Mar 31, 2014 | 15.35 Mn |
| Mar 31, 2014 | 15.35 Mn |
| Dec 31, 2013 | 9.80 Mn |
| Dec 31, 2013 | 9.80 Mn |
| Sep 30, 2013 | 9.50 Mn |
| Sep 30, 2013 | 9.50 Mn |
| Jun 30, 2013 | 9.90 Mn |
| Jun 30, 2013 | 9.90 Mn |
| Mar 31, 2013 | 9.20 Mn |
| Mar 31, 2013 | 9.20 Mn |
| Dec 31, 2012 | 9.07 Mn |
| Dec 31, 2012 | 9.07 Mn |
| Sep 30, 2012 | 9.50 Mn |
| Sep 30, 2012 | 9.50 Mn |
| Jun 30, 2012 | 9.90 Mn |
| Jun 30, 2012 | 9.90 Mn |
| Mar 31, 2012 | 9.93 Mn |
| Mar 31, 2012 | 9.93 Mn |
| Dec 31, 2011 | 7.48 Mn |
| Dec 31, 2011 | 7.48 Mn |
| Sep 30, 2011 | 7.40 Mn |
| Sep 30, 2011 | 7.40 Mn |
| Jun 30, 2011 | 7.20 Mn |
| Jun 30, 2011 | 7.20 Mn |
| Mar 31, 2011 | 6.90 Mn |
| Mar 31, 2011 | 6.90 Mn |
| Dec 31, 2010 | 4.17 Mn |
| Dec 31, 2010 | 4.17 Mn |
| Sep 30, 2010 | 4.10 Mn |
| Sep 30, 2010 | 4.10 Mn |
| Jun 30, 2010 | 3.60 Mn |
| Jun 30, 2010 | 3.60 Mn |
| Mar 31, 2010 | 3.12 Mn |
| Mar 31, 2010 | 3.12 Mn |